文献速递产科母胎医学

亚洲人群早孕期子痫前期预测模型筛查性能的前瞻性评估

Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population.
PubMed 文献 · Am J Obstet Gynecol · 2019-10-04

本研究为前瞻性、非干预、多中心研究,纳入亚洲7个地区11个中心10935例11-13+6周单胎妊娠,评估胎儿医学基金会贝叶斯模型、美国妇产科医师学会(ACOG)和英国国家卫生与临床优化研究所(NICE)推荐对早产子痫前期的预测性能。结果显示胎儿医学基金会三联试验在5%、10%、15%、20%固定假阳性率下对早产子痫前期的检出率分别为48.2%、64.0%、71.8%、75.8%,优于ACOG和NICE推荐方法。

要点

  • 胎儿医学基金会贝叶斯模型在亚洲人群中对早产子痫前期预测有效,优于ACOG和NICE推荐方法。
  • 三联试验在5%、10%、15%、20%假阳性率下检出率分别为48.2%、64.0%、71.8%、75.8%。
  • ACOG推荐在20.4%假阳性率下检出率54.6%;NICE指南在5.5%假阳性率下检出率26.3%。

核心结论

  • 基于大量女性,本研究表明胎儿医学基金会贝叶斯模型在亚洲人群中有效预测早产子痫前期,且该筛查方法优于ACOG和NICE推荐的方法。
  • 胎儿医学基金会预测模型可通过现有常规产前保健基础设施作为常规产前保健的一部分实施。

研究设计与样本

  • 前瞻性、非干预、多中心研究,纳入2016年12月至2018年6月亚洲7个地区11个招募中心的10935例11-13+6周单胎妊娠。
  • 记录母亲特征及内科、产科和药物史,按标准化方案测量平均动脉压和子宫动脉搏动指数,用自动分析仪测量母血清胎盘生长因子浓度,并转换为中位数倍数。
  • 使用胎儿医学基金会贝叶斯模型计算每个参与者早产子痫前期(<37周)和任何孕周子痫前期的个体化风险,评估三联试验筛查性能并调整阿司匹林使用。
  • 通过受试者工作特征曲线评估预测性能,通过校准斜率和整体校准评估校准度,并将胎儿医学基金会模型检出率与ACOG和NICE推荐衍生的模型比较。

主要发现

  • 224例(2.05%)发生子痫前期,其中73例(0.67%)为早产子痫前期。
  • 早产子痫前期妊娠中平均动脉压和子宫动脉搏动指数的中位数倍数均值显著高于无子痫前期者(平均动脉压1.099 vs 1.008,P<.001;子宫动脉搏动指数1.188 vs 1.063,P=.006),胎盘生长因子中位数倍数均值显著低于无子痫前期者(0.760 vs 1.100,P<.001)。
  • 胎儿医学基金会三联试验在5%、10%、15%、20%固定假阳性率下对早产子痫前期的检出率分别为48.2%、64.0%、71.8%、75.8%,与既往发表的胎儿医学基金会研究数据相当。
  • 采用ACOG推荐的筛查在20.4%假阳性率下检出率为54.6%;采用NICE指南的检出率为26.3%,假阳性率5.5%。

临床怎么用

  • 胎儿医学基金会预测模型可通过现有常规产前保健基础设施作为常规产前保健的一部分实施。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The administration of aspirin <16 weeks gestation to women who are at high risk for preeclampsia has been shown to reduce the rate of preterm preeclampsia by 65%. The traditional approach to identify such women who are at risk is based on risk factors from maternal characteristics, obstetrics, and medical history as recommended by the American College of Obstetricians and Gynecologists and the National Institute for Health and Care Excellence. An alternative approach to screening for preeclampsia has been developed by the Fetal Medicine Foundation. This approach allows the estimation of patient-specific risks of preeclampsia that requires delivery before a specified gestational age with the use of Bayes theorem-based model. OBJECTIVE: The purpose of this study was to examine the diagnostic accuracy of the Fetal Medicine Foundation Bayes theorem-based model, the American College of Obstetricians and Gynecologists, and the National Institute for Health and Care Excellence recommendations for the prediction of preterm preeclampsia at 11-13+6 weeks gestation in a large Asian population STUDY DESIGN: This was a prospective, nonintervention, multicenter study in 10,935 singleton pregnancies at 11-13+6 weeks gestation in 11 recruiting centers across 7 regions in Asia between December 2016 and June 2018. Maternal characteristics and medical, obstetric, and drug history were recorded. Mean arterial pressure and uterine artery pulsatility indices were measured according to standardized protocols. Maternal serum placental growth factor concentrations were measured by automated analyzers. The measured values of mean arterial pressure, uterine artery pulsatility index, and placental growth factor were converted into multiples of the median. The Fetal Medicine Foundation Bayes theorem-based model was used for the calculation of patient-specific risk of preeclampsia at <37 weeks gestation (preterm preeclampsia) and at any gestation (all preeclampsia) in each participant. The performance of screening for preterm preeclampsia and all preeclampsia by a combination of maternal factors, mean arterial pressure, uterine artery pulsatility index, and placental growth factor (triple test) was evaluated with the adjustment of aspirin use. We examined the predictive performance of the model by the use of receiver operating characteristic curve and calibration by measurements of calibration slope and calibration in the large. The detection rate of screening by the Fetal Medicine Foundation Bayes theorem-based model was compared with the model that was derived from the application of American College of Obstetricians and Gynecologists and National Institute for Health and Care Excellence recommendations. RESULTS: There were 224 women (2.05%) who experienced preeclampsia, which included 73 cases (0.67%) of preterm preeclampsia. In pregnancies with preterm preeclampsia, the mean multiples of the median values of mean arterial pressure and uterine artery pulsatility index were significantly higher (mean arterial pressure, 1.099 vs 1.008 [P<.001]; uterine artery pulsatility index, 1.188 vs 1.063[P=.006]), and the mean placental growth factor multiples of the median was significantly lower (0.760 vs 1.100 [P<.001]) than in women without preeclampsia. The Fetal Medicine Foundation triple test achieved detection rates of 48.2%, 64.0%, 71.8%, and 75.8% at 5%, 10%, 15%, and 20% fixed false-positive rates, respectively, for the prediction of preterm preeclampsia. These were comparable with those of previously published data from the Fetal Medicine Foundation study. Screening that used the American College of Obstetricians and Gynecologists recommendations achieved detection rate of 54.6% at 20.4% false-positive rate. The detection rate with the use of National Institute for Health and Care Excellence guideline was 26.3% at 5.5% false-positive rate. CONCLUSION: Based on a large number of women, this study has demonstrated that the Fetal Medicine Foundation Bayes theorem-based model is effective in the prediction of preterm preeclampsia in an Asian population and that this method of screening is superior to the approach recommended by American College of Obstetricians and Gynecologists and the National Institute for Health and Care Excellence. We have also shown that the Fetal Medicine Foundation prediction model can be implemented as part of routine prenatal care through the use of the existing infrastructure of routine prenatal care.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Chaemsaithong P, Pooh RK, Zheng M, et al. Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population. Am J Obstet Gynecol. 2019. PMID: 31589866. doi:10.1016/j.ajog.2019.09.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。